Compound details
Gentioside
| Compound ID | CDAMM02658 |
|---|---|
| Common name | Gentioside | IUPAC name | 1-hydroxy-7-methoxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyxanthen-9-one |
| Molecular formula | C25H28O14 |
| Retention time | 5.29 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 553.161 | Theoretical mz | 553.155 |
| Error | 11.07 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.3644 |
| Inchi key | DNIDCQUDANKQTL-LWAOGCTDNA-N |
|---|---|
| Smiles | O=C1C2=CC(OC)=CC=C2OC3=CC(OC4OC(COC5OCC(O)C(O)C5O)C(O)C(O)C4O)=CC(O)=C13 |
| Superclass | Organoheterocyclic compounds |
| Class | Benzopyrans |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| Q9NUW8 | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | T33492 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| Q9UK17 | KCND3 | Voltage-gated potassium channel Kv4.3 | T74500 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |
| T74500 | DI0004 | Acidosis | [ICD-11: 5C73] | Q9UK17 | KCND3 |